dapsone has been researched along with acedapsone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (65.22) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Bera, S; Mondal, D | 1 |
| Fasal, P; Jano, B; Russell, DA; Shepard, CC; Worth, RM | 2 |
| Anand, LC; Rathore, BS | 1 |
| Levy, L; Peters, JH | 1 |
| Gordon, GR; Levy, L; Murray, JF; Peters, JH; Russell, DA; Scott, GC; Shepard, CC; Vincin, DR | 1 |
| Iyer, CG; Ramanujam, K; Ramu, G | 1 |
| Levy, L; Shepard, CC | 1 |
| Brinkman, MB; Mattern, EM; van Gend, HW | 1 |
| Ellard, GA | 1 |
| Jacobs, RL; Steinkampf, RW; Werbel, LM; Worth, DF | 1 |
| Rossan, RN; Schmidt, LH | 1 |
| Keeler, RF | 1 |
| Neelan, PN; Noordeen, SK; Sivaprasad, N | 1 |
| Munaf, A; Neelan, PN; Noordeen, SK | 1 |
| Desikan, KV; Ramu, G; Sengupta, U | 1 |
| Coleman, MD; Gardiner, JM; Pahal, KK | 1 |
| Blanc, LJ | 1 |
| Smith, CM; Smith, WC | 1 |
| Balasundaram, B; Ebenezer, G; Natrajan, MM; Rao, GS; Shaw, IN | 1 |
| Christian, M; Jesudasan, K; Kurian, N; Rao, GS; Shaw, IN | 1 |
| Joseph, G; Norman, G; Richard, J | 1 |
| George, J | 1 |
3 review(s) available for dapsone and acedapsone
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
Topics: Acedapsone; Clinical Trials as Topic; Cost-Benefit Analysis; Dapsone; Humans; Leprostatic Agents; Leprosy; Rifampin; Risk Factors; Topography, Medical | 2000 |
Metabolism and interactions of antileprosy drugs.
Topics: Acedapsone; Biological Availability; Biotransformation; Clofazimine; Cytochrome P-450 CYP3A; Dapsone; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Leprostatic Agents; Leprosy; Metabolic Clearance Rate; Metabolic Networks and Pathways; Mycobacterium leprae; Rifampin | 2020 |
7 trial(s) available for dapsone and acedapsone
| Article | Year |
|---|---|
Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.
Topics: Acedapsone; Animals; Clinical Trials as Topic; Dapsone; Humans; Injections, Intramuscular; Leprosy; Mice; Mycobacterium leprae; Time Factors | 1976 |
A preliminary report on a therapeutic trial with acedapsone in lepromatous leprosy.
Topics: Acedapsone; Adult; Clinical Trials as Topic; Dapsone; Humans; Leprosy; Male | 1975 |
The number of Mycobacterium leprae in the pretreatment biopsy-specimen does not determine the rate of response of patients with lepromatous leprosy to chemotherapy with acedapsone.
Topics: Acedapsone; Animals; Clinical Trials as Topic; Dapsone; Drug Evaluation; Humans; Leprosy; Mice; Mycobacterium leprae; Random Allocation; Skin | 1986 |
Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
Topics: Acedapsone; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Leprosy; Male; Middle Aged; Rifampin; Trinidad and Tobago | 1984 |
Chemoprophylaxis against leprosy with acedapsone.
Topics: Acedapsone; Adolescent; Age Factors; Child; Child, Preschool; Dapsone; Female; Humans; Infant; Leprosy; Male; Sex Factors | 1983 |
Chemoprophylaxis against leprosy with acedapsone. An interim report.
Topics: Acedapsone; Adolescent; Age Factors; Child; Child, Preschool; Clinical Trials as Topic; Dapsone; Double-Blind Method; Female; Humans; India; Infant; Leprosy; Male; Time Factors | 1980 |
Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Topics: Acedapsone; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Microbial Sensitivity Tests; Mycobacterium leprae; Recurrence; Rifampin; World Health Organization | 2004 |
13 other study(ies) available for dapsone and acedapsone
| Article | Year |
|---|---|
Letter: Prevention of leprosy by acedapsone.
Topics: Acedapsone; Adult; Child; Dapsone; Humans; Leprosy; Micronesia | 1975 |
Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia.
Topics: Acedapsone; Adult; Child; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Micronesia; Patient Compliance; Recurrence | 1979 |
Activity and effective serum level of repository sulphones (DADDS) in lepromatous leprosy.
Topics: Acedapsone; Adult; Dapsone; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Leprosy; Male; Middle Aged | 1979 |
Acedapsone treatment of leprosy patients: response versus drug disposition.
Topics: Acedapsone; Acetylation; Adult; Child; Dapsone; Female; Humans; Leprosy; Male; Phenotype; Sulfamethazine | 1977 |
[Automated determination of 4,4'-diaminodiphenylsulfone (DDS) and acetyl metabolites (MADDS and DADDS) in milk with the FAST-LC system].
Topics: Acedapsone; Animals; Autoanalysis; Cattle; Chromatography, Liquid; Dapsone; Milk; Spectrophotometry, Ultraviolet | 1986 |
Combined treatment for lepromatous leprosy.
Topics: Acedapsone; Animals; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprostatic Agents; Leprosy; Mice; Prothionamide; Rifampin; Thioacetazone | 1980 |
Long-acting, repository antimalarial agents. Duration of protection in mice and monkeys following administration of pyrimethamine pamoate.
Topics: Acedapsone; Animals; Dapsone; Drug Combinations; Female; Injections, Intramuscular; Macaca fascicularis; Malaria; Male; Mice; Plasmodium berghei; Pyrimethamine; Time Factors; Triazines | 1984 |
Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.
Topics: Acedapsone; Animals; Antimalarials; Dapsone; Drug Combinations; Drug Resistance, Microbial; Macaca mulatta; Malaria; Particle Size; Plasmodium falciparum; Plasmodium vivax; Proguanil; Pyrimethamine; Time Factors; Triazines | 1984 |
Influence of sulphone therapy on lepromin reaction.
Topics: Acedapsone; Adult; Dapsone; Humans; Lepromin; Leprosy | 1980 |
The effect of acetylation and deacetylation on the disposition of dapsone and monoacetyl dapsone hydroxylamines in human erythrocytes in-vitro.
Topics: Acedapsone; Acetylation; Adult; Amines; Anti-Infective Agents; Chromatography, High Pressure Liquid; Dapsone; Dealkylation; Erythrocytes; Folic Acid; Folic Acid Antagonists; Glucose; Hematinics; Humans; In Vitro Techniques; Methemoglobin; Methotrexate | 1996 |
Trials of preventive therapy.
Topics: Acedapsone; Chemoprevention; Clinical Trials as Topic; Dapsone; Humans; India; Leprostatic Agents; Leprosy; Pacific Islands; Rifampin | 1999 |
Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Topics: Acedapsone; Adolescent; Adult; Animals; Child; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Mice, Inbred CBA; Mycobacterium leprae; Recurrence; Rifampin | 2000 |
Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Topics: Acedapsone; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Rifampin; Skin; Treatment Outcome; World Health Organization | 2003 |